VTRS
Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
2022-12-29–present
Board Member
Viatris Inc (VTRS)Equibles does not estimate personal net worth.
Get an email with a short summary when Viatris Inc publishes a filing, an earnings call transcript or a press release.
Get VTRS alertsScott Smith is recorded as Board Member at Viatris Inc (VTRS) since December 29, 2022 and CEO at Viatris Inc (VTRS). Viatris Inc reported in an 8-K filed December 29, 2022 that Scott Smith was appointed Class I director, effective December 29, 2022. Scott Smith has spoken on 14 earnings calls and 1 other investor event across 1 company, most recently for Viatris Inc on November 5, 2026. Viatris Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Viatris Inc includes Scott A. Smith (CEO and Board Member), Robert J. Coury (Chairman and Board Member), Sanjeev Narula (CFO) and 7 others.
“On December 29, 2022, the Board appointed Elisha Finney and Scott Smith to the Board, effective immediately.”
“We're pleased with our strong third quarter performance, which reflects continued momentum across our businesses. As we've been saying, we believe we've entered a new phase of sustained growth for VHRs.”
“We're off to an exceptional start in 2026. We delivered another strong quarter that reinforces our confidence in the strategy we outlined earlier this year.”
“We're pleased to report another strong quarter. We're off to an exceptional start to the year.”
“We're very excited about getting going here, talking about what's been accomplished to date, where we sit today and where we're going, particularly over the next three to five years.”
“2025 was a strong year for Beatrice, and I'm very proud of what we are able to accomplish across all our strategic priorities. The result of all that great work is that we have positioned the company to enter a period of long-term sustainable growth beginning in 2026.”
2022-12-29–present
VTRS
Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
2022-12-29–present